Alzheimer's

Discussion in 'Merck' started by anonymous, Nov 3, 2016 at 10:58 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So now we read: "Potentially important new Alzheimer’s disease research has been presented by US pharma giant Merck & Co (NYSE: MRK) around its drug verubecestat." Another contribution from Schering-Plough. Along with Keytruda, via Organon. So where's Merck Research??
     

  2. anonymous

    anonymous Guest

    Guess Merck has converted the lab into a merger and acquisitions office. MDs and Phds are now Attorneys . It's the new world order.
     
  3. anonymous

    anonymous Guest

    Yeah... Litigators, Lawyers, Esquires, Attorneys, Jurists.... how many phucking names will these scumbags go by?... I will give you a few more... Dickheads, Losers, Ambulance Chasers, Recievers of people's misfortunes, Masters of the English Language, Masterbaitors,Arrogant Assholes, Democratic Shills, Control Freaks, ... please add on as you please... these people would have NO clue how to run a business, or run a functional family...
     
  4. anonymous

    anonymous Guest

    hahahahaha! Your drug isn't going to make it!!! Tough shit. Good enough for you fuck asses. love it
     
  5. anonymous

    anonymous Guest

    I love it when schmerck steps in shit. Makes my week fucktards
     
  6. anonymous

    anonymous Guest

    Back to the original question: Where's Merck Research been..., after all these years? After all the millions of dollars??!!
     
  7. anonymous

    anonymous Guest

    Apparently another promising therapy has reached a dead end. Merck is running out of options to fuel growth .
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    Confusing Lilly's anti-A beta antibody with a BACE inhibitor, are we?
     
  10. anonymous

    anonymous Guest

    Any idea when some data might get reported for Merck's BACE inhibitor?
     
  11. anonymous

    anonymous Guest

    Another one bites the dust.
     
  12. anonymous

    anonymous Guest

    Merck research is barely alive. Merck won't take bad molecules into big studies. Another Plough promise What is next clinical molecue from SP Organon